Worried about skyrocketing prescription drug costs? Medicare's new spending cap is bringing welcome relief to seniors, with ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Biden-era ...

Fixed-income seniors are bearing the brunt of skyrocketing prescription drug prices, according to a shocking new analysis.

Relief is coming for more than 5 million Medicare beneficiaries who rely on expensive prescription medications.

President Donald Trump, ever the negotiator, is angling to lower drug prices through his Most Favored Nation policy. But will it work? And will biotech stocks take a hit?

The high cost of prescription drugs in America has again moved back into the political spotlight, with President Trump ...

Looming threats to the pharmaceutical supply chain have brought fresh attention to onshoring. Experts say innovation is ...

Since President Trump was sworn into office for a second term, he has proposed or initiated changes impacting Medicare.

Learn about the benefits that become permanent features of Medicare in 2026 and how they have been changed or updated since ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

In his first term, Trump made a lot of noise about lowering drug prices but accomplished little of consequence. The noise continues, but it is now accompanied by new ill-conceived initiatives, ...

The Trump administration hopes to issue a rule by the end of this year empowering regulators to “very forcefully” go after companies that don’t share information on drug costs, the CMS administrator ...